Post-approval studies (Phase 4)Study completedNCT02607111
What this trial is testing
A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients
Who this might be right for
Kidney Failure
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 15